Todd O. Davis Mr. Davis is currently the President and Founder of TDOrtho, an orthopedic and medtech consulting business.  Mr. Davis has spent the past 33 years serving the global orthopedic industry as a leader in marketing, sales management and general management. Heading teams at Zimmer, Biomet and Zimmer Biomet, he drove differentiated product development as General Manager of the world’s largest knee business. Mr. Davis provides subject matter expertise (SME) in total joint (knee and hip) replacements including implants, instruments and services; ortho robotics and orthopedic diagnostics.   Brian Hodorek Mr. Hodorek is currently President/CEO and Co-Founder of Ignite [...]

FORT WAYNE, IN – BioPoly LLC has announced that the U.S. Food and Drug Administration has granted clearance for its BioPoly® Lesser Toe System, BioPoly’s second FDA-cleared product in the U.S. market.BioPoly’s Great Toe System was the first product to receive FDA clearance, which is currently being sold in the US for patients with arthritis leading to a stiff or painful great toe. “We are excited about achieving our second FDA clearance with BioPoly technology as we continue to build momentum in our extremity portfolio. The Great Toe System is performing well clinically and we expect the same from our [...]

FORT WAYNE, IN – BioPoly LLC announced today that Ryan Schlotterback has joined the executive management team as the President and Chief Executive Officer.  An experienced business leader, Ryan, has succeeded Herb Schwartz and has assumed responsibilities of this role.  The focus of the Company is changing to commercialization of its FDA cleared products; therefore, Dr. Schwartz, co-founder of BioPoly, will remain on the executive management team as Chief Technology Officer and Chairman of the Board.  Sheila Schwartz, also a co-founder of BioPoly and a member of the executive management team, will continue to lead operations as Chief Operating Officer. [...]

FORT WAYNE, IN – BioPoly LLC has announced that the first BioPoly® Great Toe surgery in the U.S. was completed on September 30, 2021. The surgery was performed by Dr. Steve Herbst of Central Indiana Orthopedics in Muncie, Indiana.“The BioPoly Great Toe implant addresses a large unmet need in the market, and we are thrilled to have it available in the U.S. now. This small implant has a lot of technology packed into it and solves many of the issues that have caused other great toe implants to fail,” said Herb Schwartz, President of BioPoly. The BioPoly® Great Toe implant [...]

FORT WAYNE, IN – BioPoly LLC has announced that the U.S. Food and Drug Administration has granted clearance for its BioPoly® Great Toe Implant.  With this FDA clearance, the BioPoly technology is available for the first time in the U.S. BioPoly first received regulatory approval in 2012 for its knee implants in Europe. “Although we have been in patients in Europe with our knee implants for nearly 10 years, we are extremely excited to be able to enter the US market with our BioPoly technology,” said Herb Schwartz, President of BioPoly. “We have a porous and non-porous stem design and [...]